A review by the National Academies of Sciences, Engineering, and Medicine examined the safety, effectiveness, and clinical utility of compounded bioidentical hormone therapy (cBHT) as an alternative to FDA-approved hormone therapies. The report highlights concerns about the widespread use of cBHT despite insufficient evidence supporting its safety and efficacy. It
